Baxter International Inc. Stock
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.37 USD | -0.66% | -1.58% | +4.42% |
Apr. 23 | Edwards Lifesciences Corporation: The story continues | |
Apr. 15 | Exact Sciences Names Aaron Bloomer CFO | MT |
Financials (USD)
Sales 2024 * | 15.11B | Sales 2025 * | 15.68B | Capitalization | 20.56B |
---|---|---|---|---|---|
Net income 2024 * | 747M | Net income 2025 * | 960M | EV / Sales 2024 * | 1.97 x |
Net Debt 2024 * | 9.15B | Net Debt 2025 * | 8.02B | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 * |
21.5
x | P/E ratio 2025 * |
17.9
x | Employees | 60,000 |
Yield 2024 * |
2.87% | Yield 2025 * |
3.1% | Free-Float | 74.06% |
Latest transcript on Baxter International Inc.
1 day | -0.66% | ||
1 week | -1.58% | ||
1 month | -5.55% | ||
3 months | +4.34% | ||
6 months | +24.48% | ||
Current year | +4.42% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 15-09-30 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 23-10-17 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 17-02-05 |
Peter Wilver
BRD | Director/Board Member | 64 | 22-05-09 |
Director/Board Member | 64 | 19-02-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.07% | 215 M€ | +12.21% | - | |
1.23% | 18 M€ | +2.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 40.37 | -0.66% | 3,465,078 |
24-04-29 | 40.64 | +1.27% | 3,262,957 |
24-04-26 | 40.13 | -0.25% | 2,013,221 |
24-04-25 | 40.23 | -1.71% | 3,568,051 |
24-04-24 | 40.93 | -0.22% | 2,161,941 |
Delayed Quote Nyse, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.42% | 20.56B | |
-3.72% | 184B | |
-2.60% | 107B | |
-3.79% | 67.78B | |
+2.66% | 50.66B | |
+16.39% | 47.64B | |
+4.60% | 41.12B | |
+1.38% | 26.3B | |
+1.52% | 26.04B | |
-1.17% | 24.71B |
- Stock Market
- Equities
- BAX Stock